{"id":24448,"date":"2023-07-17T16:43:54","date_gmt":"2023-07-17T16:43:54","guid":{"rendered":"https:\/\/www.goodacademic.com\/blog\/questions\/recent-breakthrough-technology-you-will-develop-a-plan-as-to-how-you-might-utilize-this-technology-to-develop-a-new-drug-diagnostic-test-etc-and-formulate-your-own-biotech-compa\/"},"modified":"2023-07-17T16:43:54","modified_gmt":"2023-07-17T16:43:54","slug":"recent-breakthrough-technology-you-will-develop-a-plan-as-to-how-you-might-utilize-this-technology-to-develop-a-new-drug-diagnostic-test-etc-and-formulate-your-own-biotech-compa","status":"publish","type":"questions","link":"https:\/\/www.goodacademic.com\/blog\/questions\/recent-breakthrough-technology-you-will-develop-a-plan-as-to-how-you-might-utilize-this-technology-to-develop-a-new-drug-diagnostic-test-etc-and-formulate-your-own-biotech-compa\/","title":{"rendered":"recent \u201cbreakthrough\u201d technology. You will develop a plan as to how you might utilize this technology to develop a new drug, diagnostic test, etc., and formulate your own biotech company around this plan."},"content":{"rendered":"

Hello,<\/span><\/p>\n

Please carefully
\nreview the instructions and assist me in correcting and expanding the
\ninformation accurately. Additionally, kindly provide prompt responses to the
\nquestions. I have prepared an outline for Checkpoint 1, focusing on the disease
\nAMD. I request that you respond to each question based on my chosen disease,
\nproviding your input as well. As indicated in the feedback, the professor
\nrecognized that the draft was generated by ChatGPT and emphasized the
\nimportance of incorporating my own thoughts and input into the responses.
\nTherefore, I kindly ask you to refrain from relying solely on ChatGPT and to
\nsupport your answers with valid and legitimate sources. Please ensure that the
\nsources cited can be easily accessed and that the information you present is
\ngenuinely extracted from these sources. I need to verify each part of the
\nanswer using reliable resources. If you have any further questions or require
\nadditional information, please let me know. It is essential that you provide
\naccurate information regarding technologies, drugs, and approaches, along with
\nthe correct citations, without any form of plagiarism. Thank you in advance for
\nyour valuable assistance.<\/span><\/p>\n

Assignment
\nInstructor for check point 1:<\/span><\/p>\n

The
\ngoal of this exercise is for you to take a \u201cbreakthrough\u201d technology and
\nattempt to apply it to a cell biological problem related to the material
\ncovered in this class.  You can choose any recent \u201cbreakthrough\u201d
\ntechnology. You will develop a plan as to how you might utilize this technology
\nto develop a new drug, diagnostic test, etc., and formulate your own biotech
\ncompany around this plan. Students must meet periodic “checkpoints”
\nto ensure they are making adequate progress on their projects (see the course
\nschedule). Final presentations are due as indicated in the course schedule. All
\nstudents will also be required to engage in final presentation interaction
\nactivities during the final two weeks of the term.<\/span><\/p>\n

 At
\nthis time, you do not need to decide on the technology\/project that will be the
\nfoundation of your start-up company idea yet. You need to present your plan of
\nhow are you going to search for your idea. For example, if you want to develop
\na new drug, you need to think about the following items:<\/span><\/p>\n

1.
\nDisease\/s what you want to fix<\/span><\/p>\n

2.
\nCurrent treatment<\/span><\/p>\n

3.
\nHow are you planning to improve it?<\/span><\/p>\n

–
\nincrease the therapeutic window<\/span><\/p>\n

–
\nimprove the delivery process<\/span><\/p>\n

–
\nreduce the side effect<\/span><\/p>\n

–
\nincrease the efficacy<\/span><\/p>\n

–
\nOther options<\/span><\/p>\n

4.
\nHow are you going to do it?<\/span><\/p>\n

–
\nWhat technology are you going to use (again – I do not need technology now). It
\nwill depend on #3<\/span><\/p>\n

–
\nWhere are you going to search for this technology?<\/span><\/p>\n

Examples:
\nScientific papers, biotech news, off-field approach (for example, use a
\ndelivery system from the agriculture field and apply it to a drug delivery).<\/span><\/p>\n

5.
\nCompetition<\/span><\/p>\n

6.
\nYour first step<\/span><\/p>\n

 <\/span><\/p>\n

MY Draft for check point 1<\/span> : <\/span><\/p>\n

1.
\nDisease<\/span><\/b>: Age-related
\nmacular degeneration (AMD)<\/i><\/b>:<\/span><\/p>\n

Age-related macular degeneration (AMD) is a crippling
\ndisorder that causes permanent blindness in those over the age of 50. This
\ncomplicated illness is the major cause of visual loss in this age group right
\nnow. To better understand the numerous mechanisms involved in the development
\nand progression of AMD, scientists have been performing genetic,
\nepidemiological, and molecular research. These studies have demonstrated that
\nthe lipid-cholesterol pathway is involved in the pathogenesis of the illness.<\/span><\/p>\n

AMD has genetic and environmental risk factors in common
\nwith other degenerative illnesses that typically affect the elderly, including
\ncardiovascular disease (CVD). The link between AMD and lipid metabolism genes
\nhas been widely researched, as has the link between AMD and different
\ncardiovascular abnormalities (Pennington & DeAngelis, 2016).<\/span><\/p>\n

2. Current treatment:<\/span><\/b><\/span><\/p>\n

\u00b7       
\n<\/span><\/span><\/span>Intravitreal
\ninjections of anti-vascular endothelial growth factor (anti-VEGF)<\/span><\/i> drugs, such as ranibizumab,
\nbevacizumab, and aflibercept. These drugs help to reduce abnormal blood vessel
\ngrowth and leakage in the retina (Hubschman, 2009).<\/span><\/p>\n

\u00b7       
\n<\/span><\/span><\/span>Photodynamic
\ntherapy (PDT)<\/span><\/i> – This treatment
\ninvolves injecting a light-activated drug into the bloodstream, followed by
\nshining a laser light onto the affected area to destroy abnormal blood vessels
\n(Wormald et al., 2007).<\/span><\/p>\n

\u00b7       
\n<\/span><\/span><\/span>Laser
\nphotocoagulation<\/span><\/i> – This procedure
\nuses a laser to seal leaking blood vessels (Virgili & Bini, 2004).<\/span><\/p>\n

3. Plan to improve treatment:<\/span><\/b><\/span><\/p>\n

Expand the Therapeutic Window<\/span><\/p>\n

Create medications or treatment regimens that attack AMD at
\nan early stage, before major vision loss develops.<\/span><\/p>\n

Identify and intervene at novel molecular targets or
\npathways implicated in AMD development.<\/span><\/p>\n

Enhance the Delivery Process:<\/span><\/p>\n

To minimize injection frequency while maintaining
\ntherapeutic medication levels, develop sustained-release formulations or other
\nmodes of administration.<\/span><\/p>\n

Investigate nanotechnology-based delivery methods (for
\nexample, nanoparticles and liposomes) to increase medication stability,
\nbioavailability, and targeted distribution to damaged tissues.<\/span><\/p>\n

Reduce Adverse Effects:<\/span><\/p>\n

Develop specialized and focused medicines that exclusively
\ninfluence the pathogenic processes linked with AMD while leaving healthy
\ntissues alone.<\/span><\/p>\n

Optimize medicine doses and monitoring methods to reduce
\nside effects.<\/span><\/p>\n

Boost Efficiency:<\/span><\/p>\n

Create combination medicines that target several mechanisms
\nimplicated in AMD etiology.<\/span><\/p>\n

Combine anti-VEGF medications with other treatments (e.g.,
\nanti-inflammatory, neuroprotective) to improve overall therapeutic efficacy.<\/span><\/p>\n

Other options include:<\/span><\/p>\n

Investigate regenerative medicine ways to repair or replace
\ndamaged retinal cells caused by AMD, such as stem cell treatment or gene
\ntherapy.<\/span><\/p>\n

4. The specific technology to be used will depend on the
\nchosen approach. Possible technologies could include:<\/span><\/b><\/span><\/p>\n

a. <\/i><\/span><\/b>Nanotechnology-based drug delivery systems<\/span><\/i> – Utilizing nanoparticles or
\nnanoscale carriers to enhance drug stability, improve bioavailability, and
\nenable targeted delivery to the affected area (Yang et al., 2021).<\/span><\/p>\n

b<\/span><\/i><\/b>. Gene therapy<\/span><\/i> – Utilizing viral vectors or
\nother methods to deliver therapeutic genes to the retina and modulate the
\nexpression of genes involved in the disease process (Moore et al., 2017).<\/span><\/p>\n

c. <\/span><\/i><\/b>Stem cell therapy<\/span><\/i> – Investigating the potential of
\nusing stem cells to replace damaged retinal cells or provide trophic support to
\nthe existing cells (O\u2019Neill et al., 2020).<\/span><\/p>\n

The search for these technologies can be conducted through
\nvarious sources, such as scientific papers, biotech news, conferences, and
\ncollaborations with research institutions working on related fields.<\/span><\/p>\n

5. Competition:<\/span><\/b><\/span><\/p>\n

There is fierce rivalry among researchers, pharmaceutical
\ncorporations, and biotech firms in the field of age-related macular
\ndegeneration. Several firms are currently exploring novel medicines and
\nmedication delivery systems in order to increase patient treatment choices.
\nAmong the businesses active in this field are Genentech, Novartis, Regeneron
\nPharmaceuticals, and Spark Therapeutics.<\/span><\/p>\n

6. The first step<\/b> would be to perform a
\nthorough examination of the existing literature, scientific publications, and
\nclinical trial databases to get a full grasp of the current level of research
\nand available technologies in the field of age-related macular degeneration.
\nThis would aid in the identification of knowledge gaps and prospective areas
\nfor development. Additionally, exploring collaborations with experts and
\ninstitutions specializing in ophthalmology and vision research would provide
\nvaluable insights and potential partnerships for advancing the development of
\nimproved treatments.<\/span><\/p>\n



\n<\/span>Instructor Feedback
\nand the questions needed to be answered for checkpoint 2 : <\/span><\/span><\/p>\n

<\/span>Based on the style of
\nyour answer, I have a feeling that ChatGPT generated it. ChatGPT is an
\nexcellent tool for a draft of your work, but you need to include your thoughts
\nand input.

\nFor Checkpoint 2, you need to provide the following information<\/b>:

\n1.           Choose one
\nimprovement of the current treatment you want to focus on. You need to justify
\nyour choice. I need to have your opinion about it.

\n2.           Pick one technology for the chosen focus
\n(in #1). You need to justify your choice. 

\n<\/span>You can look at the recent
\nprogress of gene therapy for AMD.<\/span><\/span><\/p>\n

 <\/span><\/p>\n

 Please provide your input and thoughts for Checkpoint 1 and answer the two questions provided in Checkpoint 2, based on the instructions given by the instructor.<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"

Hello, Please carefully review the instructions and assist me in correcting and expanding the information accurately. Additionally, kindly provide prompt responses to the questions. I have prepared an outline for Checkpoint 1, focusing on the disease AMD. I request that you respond to each question based on my chosen disease, providing your input as well. […]<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"open","ping_status":"closed","template":"","meta":[],"disciplines":[275],"paper_types":[],"tagged":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.goodacademic.com\/blog\/wp-json\/wp\/v2\/questions\/24448"}],"collection":[{"href":"https:\/\/www.goodacademic.com\/blog\/wp-json\/wp\/v2\/questions"}],"about":[{"href":"https:\/\/www.goodacademic.com\/blog\/wp-json\/wp\/v2\/types\/questions"}],"author":[{"embeddable":true,"href":"https:\/\/www.goodacademic.com\/blog\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.goodacademic.com\/blog\/wp-json\/wp\/v2\/comments?post=24448"}],"version-history":[{"count":0,"href":"https:\/\/www.goodacademic.com\/blog\/wp-json\/wp\/v2\/questions\/24448\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.goodacademic.com\/blog\/wp-json\/wp\/v2\/media?parent=24448"}],"wp:term":[{"taxonomy":"disciplines","embeddable":true,"href":"https:\/\/www.goodacademic.com\/blog\/wp-json\/wp\/v2\/disciplines?post=24448"},{"taxonomy":"paper_types","embeddable":true,"href":"https:\/\/www.goodacademic.com\/blog\/wp-json\/wp\/v2\/paper_types?post=24448"},{"taxonomy":"tagged","embeddable":true,"href":"https:\/\/www.goodacademic.com\/blog\/wp-json\/wp\/v2\/tagged?post=24448"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}